Maker Of Fatal Herbal Injectable Drug In China Ordered Closed
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities ordered closed a plant the source of an herbal injection drug that killed one and sickened others. Wusuli River Pharmacy has begun recalling its Shuanghuanglian, cited as the cause of a patient who died after being injected with it. The Ministry of Health and the State FDA said that since that case, other suspect batches of the injectable have been found, so it ordered hospitals and pharmacists to suspend using or selling the drug. (Click here for more
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.